Ignite Creation Date:
2024-05-06 @ 4:11 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04901299
Status:
WITHDRAWN
Last Update Posted:
2023-08-01
First Post:
2021-05-18
Brief Title:
Fulvestrant Neratinib In Breast Cancer
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Invasive Breast Cancer |
| Stage IV Metastatic Breast Cancer |
| Metastatic Breast Cancer |
| ER Positive Breast Cancer |
| PR-Positive Breast Cancer |
| HER2-negative Breast Cancer |